Skip to content

Clinical trials

Phase 1/2 Pseudomonas Infections trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pseudomonas Infections Phase: Phase 1/2 Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20083
20181
20201
20212
20222
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Unknown status3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Humanigen, Inc.2
Aridis Pharmaceuticals, Inc.1
Armata Pharmaceuticals, Inc.1
Immunsystem AB1
Kenta Biotech Ltd1
MB PHARMA s.r.o.1
National Institute of Allergy and Infectious Diseases (NIAID)1
Precisio Biotix Therapeutics, Inc.1
Respirion Pharmaceuticals Pty Ltd1
Technophage, SA1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pseudomonas Infections12
Cystic Fibrosis7
Staphylococcal Infections3
Pneumonia, Ventilator-Associated2
Acinetobacter Infections1
Bacterial Infections1
Bronchiolitis Obliterans Syndrome1
Diabetic Foot1
Healthcare-Associated Pneumonia1
Infections1

Trials

Showing 51 to 12 of 12. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.